Health
Enzyme biofactories to enhance cord blood transplants – EurekAlert
Stem cell trafficking to the bone marrow is improved by enzyme manufactured in silkworms and yeast.
IMAGE: The researchers showed that their yeast- and silkworm-derived enzyme far outperformed commercial sources of the enzyme made in standard expression systems.
view more
Credit: © 2020 KAUST; Heno Hwang
A new way of producing an enzyme called fucosyltransferase VI (FTVI) in the lab could help enhance the therapeutic potential of cord blood transplants.
Cord blood is currently used to treat more than 80 life-threatening conditions, ranging from cancer and immune deficiency to metabolic and genetic…
-
Noosa News19 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Business22 hours ago$10,000 invested in ANZ shares 5 years ago is now worth…
-
Noosa News21 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General20 hours agoInternal Revenue Service starts cutting 20,000 workers